Nous avons le plaisir de vous annoncer que Genexpath participera au prochain congrès de la SFH. Venez nous rencontrer et échanger avec notre équipe !

La Société Française d’Hématologie (SFH) est une organisation médicale regroupant des professionnels de la santé spécialisés en hématologie. Elle vise à promouvoir la recherche, l’éducation et la formation dans le domaine des maladies du sang en organisant des événements scientifiques et en favorisant la collaboration entre les membres. 

  La SFH contribue également à la promotion de la recherche clinique et fondamentale, ainsi qu’à l’amélioration des pratiques cliniques pour la prise en charge des patients atteints de troubles hématologiques en France. 

📅 Date : du 02 au 04 Avril 2025
📍 Lieu : Palais de congrès, Paris

Nous avons hâte de vous y retrouver !

CARREFOUR PATHOLOGY 2024, organized by the French Society of Pathology (SFP), will take place at the CNIT Forest in Paris la Défense, from November 20 to 22, 2024.

Ce congrès reste un moment unique de rencontres, d’échanges, d’enseignement et de diffusion des savoirs entre les professionnels de l’Anatomie et Cytologie Pathologiques.

For more information about the congress: https://carrefour-pathologie.org/

Genexpath will be at Cambridge Lymphoma Biology International Symposium at Magdalene College, Cambridge, England, from September 17 to 18, 2024.

This symposium is an event that brings together researchers and clinicians with an interest in the biology of lymphomas and CLL. For more information: Haematology Event: Cambridge Lymphoma Biology International Symposium | Cambridge Stem Cell Institute

Genexpath will be at 36th European Congress of Pathology (ECP 2024) organized by theEuropean Society of Pathology at the Fortessa da Basso in Florence, Italy, from September 7 to 10, 2024. We will be present with Clinisciences, our European distributor.

This European Pathology Congress is a scientific event bringing together pathologists, clinicians, molecular biologists, geneticists, bioinformaticians, computer experts, and the congress's industrial partners in the field of pathology in Europe. For more information about the congress: https://www.esp-congress.org/

Genexpath will be taking part in the European Hematology Association congress in Madrid at IFEMA Madrid Recinto Ferial from June 13 to 16, 2024.

The EHA (European Hematology Association) congress is an annual scientific event bringing together researchers, clinicians and healthcare experts in the field of hematology in Europe. Its aim is to promote excellence in the research, diagnosis and treatment of blood disorders. The meeting provides a platform to present and discuss recent advances in hematology, covering basic research, innovative therapies and clinical practices. The EHA congress is a major event for the European and global hematology community. Translated with DeepL.com (free version)

Genexpath will be present at Viva Technology from May 22 to 24, 2024 at the Porte de Versailles exhibition center in Paris, stand D53.

We'll be there with the We Are Normandy collective and 17 other companies

For four days each year, VIVATECH brings together entrepreneurs, start-ups, investors, researchers and enthusiasts from all over the world, making it Europe's biggest event in this field.

The aim of the show is to promote innovation to bring about positive change in business and society.

The show features conferences, exhibitions and a variety of experiences. VIVATECH celebrates today's innovations and tomorrow's inventions through technological advances.

Sectors as diverse as agriculture, construction, communications, culture, cybersecurity, entertainment, finance, health and transport are all impacted by these technological advances, making VIVATECH a must-attend event.

Find out more about the We Are Normandy collective: https://wearenormandy.nwx.fr/

Genexpath will be present at the Meet2Win convention on May 16 and 17, 2024 at the Cité Mondiale Convention Center in Bordeaux.

Meet2Win is an annual conference that brings together pharmaceutical industry players, investors and healthcare innovators to facilitate partnerships and the exchange of ideas. The event aims to promote innovation and the development of new treatments in the healthcare field.

Genexpath will be present at the 44thème SFH congress from March 27 to 29 2024 at the Palais des Congrès de la Porte Maillot. 

  

The French Society of Hematology (SFH) is a medical organization of healthcare professionals specialized in hematology. It aims to promote research, education and training in the field of blood disorders by organizing scientific events and fostering collaboration between members. 

  

SFH also contributes to the promotion of clinical and basic research, and to the improvement of clinical practices for the care of patients with hematological disorders in France. 

Genexpath was present at the LYSA days on January 31, February 1 and February 2, 2024 in Tours..

These days provide an opportunity to disseminate information and scientific advances relating to the understanding and treatment of lymphomas. They bring together healthcare professionals and industrial partners present at the congresses. 

LYSA, or Lymphoma Study Association, is an autonomous network dedicated to clinical research in lymphoma. It specializes in the conduct of clinical studies, from the first application of new treatments to humans, to the establishment of reference therapeutic strategies. 

Carrefour Pathologie is the annual national congress of pathological anatomy and cytology (ACP) organized by the Société Française de Pathologie (SFP).

Carrefour Pathologie offers a dense 3-day program with SFP plenary lectures, SFP symposia, three histoseminars, specialty clubs, two days of "medico-technical pathways" specially organized for and with technicians and managers, and sessions of oral and poster scientific communications.

The scientific program covers both practical diagnostic aspects and innovative themes, always based on the two major pillars of development for pathology: imaging on the one hand, and molecular pathology on the other.

The integration of artificial intelligence into the practice of PCR and the identification of tissue biomarkers in connection with targeted therapies and immunotherapy are also widely covered during these 3 days of congress.